Archean Chemical Industries Limited has successfully concluded its postal ballot voting process, with shareholders approving all three proposed resolutions through remote e-voting. The voting process ended on March 12, 2026, at 5:00 PM IST, marking a significant milestone in the company's leadership restructuring.

Postal Ballot Overview

The postal ballot was conducted under the supervision of V. Sudarsan Babu of V. Sudarsan Babu & Associates, who served as the appointed scrutinizer. The voting process commenced on February 11, 2026, and allowed shareholders as of the record date of February 06, 2026, to participate in the decision-making process.

Resolution Results

All three ordinary resolutions were successfully passed with varying levels of shareholder support across different categories.

Resolution 1: Executive Vice Chairman Appointment

The first resolution to designate Mr. P. Ranjit (DIN: 01952929) as Executive Vice Chairman received mixed response from institutional investors but strong overall support.

Resolution 2: Director Appointment

The appointment of Mr. Rampraveen Swaminathan (DIN: 01300682) as Director received significantly higher approval rates across all shareholder categories.

Resolution 3: Managing Director Appointment

The third resolution for appointing Mr. Rampraveen Swaminathan as Managing Director also achieved strong shareholder support.

Leadership Appointments

The approved resolutions bring significant changes to the company's leadership structure:

• Mr. P. Ranjit has been elevated from Managing Director to Executive Vice Chairman (Whole-Time Director) for a five-year term from January 22, 2026, to January 21, 2031
• Mr. Rampraveen Swaminathan has been appointed as both Director and Managing Director for the same five-year period

Both appointments are not liable to retire by rotation and include remuneration within the limits prescribed under the Companies Act, 2013.

Voting Participation

The postal ballot saw substantial participation with 78.19% of total outstanding shares being voted. The promoter group demonstrated strong support with 95.33% participation rate, while public institutions showed 74.06% participation. Notably, one shareholder holding 45 shares abstained from voting across all resolutions.

Compliance and Documentation

The voting results and scrutinizer's report have been made available on the company's website at www.archeanchemicals.com and on MUFG Intime's platform. The process was conducted in compliance with Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and relevant provisions of the Companies Act, 2013.

Archean Chemical Industries Limited has announced its participation in an upcoming investor conference, providing an opportunity for engagement with analysts and institutional investors. The company has formally notified the stock exchanges about this scheduled interaction under regulatory compliance requirements.

Conference Details

The chemical company will participate in IIFL's 17th Enterprising India Global Investors' Conference, scheduled for February 25, 2026. The event details are outlined below:

Regulatory Compliance and Information Sharing

The company has emphasized its commitment to regulatory compliance and transparent communication practices. All discussions during the investor interactions will be based exclusively on publicly available information. Archean Chemical Industries has specifically stated that no unpublished price sensitive information (UPSI) is intended to be discussed during these meetings.

Operational Flexibility

The company has noted that changes to the schedule may occur due to exigencies on the part of participants or the company itself. This flexibility ensures that the conference can adapt to any unforeseen circumstances while maintaining the quality of investor interactions.

Information Accessibility

In line with transparency requirements, the company has confirmed that information regarding this investor conference will be made available on its official website at www.archeanchemicals.com . This ensures that all stakeholders have access to relevant details about the company's investor engagement activities.

The notification was signed by Vijayaraghavan N E, Company Secretary & Compliance Officer, and submitted to both the National Stock Exchange of India Limited and BSE Limited as part of the company's listing obligations under SEBI regulations.